ABBVIE INC. vs. Amneal Pharmaceuticals, Inc. Class A Common Stock
ABBV
ABBVIE INC.
$294.98 +0.37%
VS AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock
$19.45 -2.51%
ABBVIE INC. (ABBV) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABBV | AMRX | |
|---|---|---|
| Market Cap | $521.41 billion | $6.95 billion |
ABBV leads on 1 of 1 size & scale factors.
Dividend
| ABBV | AMRX | |
|---|---|---|
| Dividend Yield | 2.47% | — |
ABBV and AMRX split the dividend factors evenly.
Risk & Sentiment
| ABBV | AMRX | |
|---|---|---|
| Short Interest | 0.85% | 2.39% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, AMRX overview, AMRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.